Metabolic and renal benefits of using sodium-glucose cotransporter type 2 inhibitors in patients with type 1 diabetes mellitus and continuous subcutaneous insulin infusion
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Metabolic and renal benefits of using sodium-glucose cotransporter type 2 inhibitors in patients with type 1 diabetes mellitus and continuous subcutaneous insulin infusion | Synapse